# Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.

> **NCT02292745** · NA · COMPLETED · sponsor: **Foundation for Liver Research** · enrollment: 53 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **RADIATION:** stereotactic radiotherapy

## Key facts

- **NCT ID:** NCT02292745
- **Lead sponsor:** Foundation for Liver Research
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12-02
- **Primary completion:** 2018-05-24
- **Final completion:** 2018-05-24
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2020-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02292745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02292745, "Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02292745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*